Richard Cappetta, President and CEO of MicroVention, Inc., said: "The HEAT trial is intended to provide evidence that our second-generation hydrogel coil technologies provide superior long-term ...

HOUSTON -- Treating medium-sized intracranial aneurysms with second-generation hydrogel coils diminished adverse outcomes compared with standard platinum coils, researchers reported here. Physicians ...

Please provide your email address to receive an email when new articles are posted on . Patients with intracranial aneurysms who underwent embolization with second-generation hydrogel-coated coils ...

MIAMI & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation ...

The LVIS® and LVIS® Jr. stents are the first stents PMA approved for stent-assisted coil embolization An intracranial aneurysm is a bulging, weak area in the wall of an artery that supplies blood to ...

US-based neuroendovascular device company MicroVention has announced a court settlement against three former members of staff accused of misappropriating trade secrets about the company’s embolic ...

DUBLIN, Oct. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j87v3m/global) has announced the addition of the "Global ...

New York, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Neurovascular Coiling Assist Devices (Neurology Devices) - Global Market Analysis and Forecast Model ...

Research and Markets has announced the addition of the "Global Neuroendovascular Coil and Non-Coil Devices Market - Growth, Trends and Forecasts (2016 - 2021)" report to their offering. The research ...